FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC)
CUSIP: 31447P100
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common stock, no par value (the "Shares")
- Shares outstanding
- 34,145,841
- Total 13F shares
- 13,599,927
- Share change
- +248,250
- Total reported value
- $112,877,891
- Price per share
- $8.30
- Number of holders
- 77
- Value change
- +$2,365,581
- Number of buys
- 40
- Number of sells
- 29
Quarterly Holders Quick Answers
What is CUSIP 31447P100?
CUSIP 31447P100 identifies FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31447P100:
Top shareholders of FENC - FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Southpoint Capital Advisors LP |
13F
|
Company |
12%
|
4,077,214
|
$24,830,233 | — | 31 Mar 2025 | |
| Solas Capital Management, LLC |
13F
13D/G
|
Company |
8.2%
from 13D/G
|
2,250,919
|
$13,708,097 | — | 31 Mar 2025 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
5.2%
|
1,782,844
|
$10,857,520 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
3.7%
|
1,250,288
|
$7,614,253 | — | 31 Mar 2025 | |
| DG Capital Management, LLC |
13D/G
13F
|
Company |
4.1%
|
1,114,692
|
$6,342,597 | $0 | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
964,620
|
$5,874,536 | — | 31 Mar 2025 | |
| HARBERT FUND ADVISORS, INC. |
13F
|
Company |
1.4%
|
466,869
|
$2,843,232 | — | 31 Mar 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
1.1%
|
361,005
|
$2,198,521 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.99%
|
338,133
|
$2,059,230 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.91%
|
311,332
|
$1,896,011 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.87%
|
296,613
|
$1,806,372 | — | 31 Mar 2025 | |
| Khalid Islam |
3/4/5
|
Director |
—
class O/S missing
|
225,000
|
$1,773,000 | — | 03 Jun 2025 | |
| Marco Maria Brughera |
3/4/5
|
Director |
—
class O/S missing
|
215,545
|
$1,698,494 | — | 03 Jun 2025 | |
| Lion Point Capital, LP |
13F
|
Company |
0.57%
|
195,700
|
$1,191,813 | — | 31 Mar 2025 | |
| Jeffrey L. Gendell |
13F
|
Individual |
0.57%
|
195,221
|
$1,188,895 | — | 31 Mar 2025 | |
| Jodi A. Cook |
3/4/5
|
Director |
—
class O/S missing
|
140,000
|
$1,103,200 | — | 03 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.41%
|
138,375
|
$842,704 | — | 31 Mar 2025 | |
| Adrian Haigh |
3/4/5
|
CHIEF OPERATING OFFICER |
—
mixed-class rows
|
1,205,738
mixed-class rows
|
$832,168 | — | 16 May 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.18%
|
61,146
|
$372,379 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
53,506
|
$325,849 | — | 31 Mar 2025 | |
| Hartford Financial Management Inc. |
13F
|
Company |
0.15%
|
49,848
|
$303,575 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
43,220
|
$263,210 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.12%
|
41,014
|
$249,775 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.1%
|
33,364
|
$203,178 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.09%
|
30,258
|
$184,271 | — | 31 Mar 2025 | |
| WEXFORD CAPITAL LP |
13F
|
Company |
0.08%
|
26,414
|
$160,860 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.08%
|
26,254
|
$159,888 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.08%
|
26,006
|
$158,377 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.07%
|
24,301
|
$147,993 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.07%
|
22,405
|
$136,447 | — | 31 Mar 2025 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.06%
|
22,000
|
$133,980 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
17,198
|
$110,053 | — | 31 Mar 2025 | |
| SHERBROOKE PARK ADVISERS LLC |
13F
|
Company |
0.05%
|
17,879
|
$108,883 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.05%
|
15,988
|
$97,367 | — | 31 Mar 2025 | |
| Pinnacle Wealth Planning Services, Inc. |
13F
|
Company |
0.05%
|
15,419
|
$93,902 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.04%
|
15,128
|
$92,130 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.04%
|
14,718
|
$89,633 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.04%
|
14,066
|
$85,662 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
13,661
|
$83,195 | — | 31 Mar 2025 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.04%
|
12,051
|
$73,391 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
11,721
|
$71,381 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.03%
|
11,664
|
$71,034 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.03%
|
10,897
|
$66,364 | — | 31 Mar 2025 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.03%
|
9,753
|
$59,396 | — | 31 Mar 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0.03%
|
8,850
|
$57,525 | — | 31 Mar 2025 | |
| Police & Firemen's Retirement System of New Jersey |
13F
|
Company |
0.02%
|
6,250
|
$38,062 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
2,934
|
$18,000 | — | 31 Mar 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.01%
|
2,451
|
$14,964 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.01%
|
1,841
|
$11,212 | — | 31 Mar 2025 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
1,698
|
$10,341 | — | 31 Mar 2025 |
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) as of Q2 2025
As of 30 Jun 2025,
FENNEC PHARMACEUTICALS INC. - Common stock, no par value (the "Shares") (FENC) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,599,927 shares.
The largest 10 holders included
Southpoint Capital Advisors LP, Solas Capital Management, LLC, Rosalind Advisors, Inc., BlackRock, Inc., VANGUARD GROUP INC, AIGH Capital Management LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, HARBERT FUND ADVISORS, INC., and MORGAN STANLEY.
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
68
Q2 2025 holders
77
Holder diff
9
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.